Long-Residence Time Peptide Antagonist for the Vasopressin V<sub>2</sub> Receptor to Treat Autosomal Dominant Polycystic Kidney Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-Residence Time Peptide Antagonist for the Vasopressin V₂ Receptor to Treat Autosomal Dominant Polycystic Kidney Disease

Published:2024-03-20 Issue:7 Volume:67 Page:5935-5944
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Xiong Xiaochun¹,Wang Naiyuan¹,Zhang Yixiao¹,Zhao Wenchao¹,Pang Ningning¹,Fu Kequan¹,Zhou Nan¹,Zhou Xueyan¹,Guo Dong¹^ORCID

Affiliation:

1. Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, Jiangsu, China

Funder

Natural Science Foundation of Jiangsu Province

National Natural Science Foundation of China

Scientific Research Foundation for Talented Scholars in Xuzhou Medical University

Jiangsu Specially Appointed Professor program

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c00217

Reference40 articles.

1. Autosomal dominant polycystic kidney disease

2. Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing

3. The cell biology of polycystic kidney disease

4. Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist

5. Vasopressin-2 Receptor Signaling and Autosomal Dominant Polycystic Kidney Disease: From Bench to Bedside and Back Again

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP